| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |